Browse studies

Find your next paid study

27,354 recruiting studies available now

Phase I Randomized, Double-blind Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Nucleus Basalis of Meynert or Substantia Nigra for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery

The investigators propose a Phase I single surgical-center, double-blinded randomized parallel clinical trial involving bilateral autologous peripheral nerve t…

Parkinson's Disease

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Craig van Horne, MD, PhDNCT06683378

Phase 2

A Phase 2 Study Evaluating the Efficacy and Safety Agent AUR103 Calcium in Patients With Advanced, Well or Moderately Differentiated Neuroendocrine Tumours (BHARAT-3)

A phase 2 Study Evaluating the Efficacy and Safety of Single Agent AUR103 Calcium in Patients with Advanced, Well or Moderately differentiated Neuroendocrine T…

Neuroendocrine (NE) TumorsAdvanced NET of GI Origin

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Aurigene Discovery Technologies LimitedNCT07640737

Observational

Development of an Alcohol, Cannabis, and Sexual Assault Risk Reduction Program for High Risk College Women, Pilot RCT

The goal of this clinical trial is to assess the feasibility of the Enhanced Assess, Acknowledge, and Act Sexual Assault Resistance Program with alcohol and ca…

Enhanced Assess, Acknowledge, and Act Sexual Assault Resistance Program With Alcohol and Cannabis Content

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT07726004

Phase 1

Phase I Study of Adoptive Immunotherapy of Refractory Viral Infection With ex Vivo Expanded Rapidly Generated Virus Specific T (R-MVST) Cells

The primary objective is to determine the safety and feasibility of administering R-MVST cells to patients with refractory viral reactivation and/or symptomati…

Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Columbia UniversityNCT05183490

Modified P200TE Data Collection

Images will be collected on the modified P200TE

Retina Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Optos, PLCNCT07796230

Observational

Feasibility of Flash-Sole in Human Trials: An Active Midsole Powered by Stacked Dielectric Elastomer Actuators for Push-Off Assistance

The goal of this clinical trial is to test a new shoe device called Flash-Sole. The Flash-Sole is designed to help support the ankle while walking. It was deve…

Motor Function

Estimated

~$10 – $750

Actual pay is set by the research site.

University of NebraskaNCT07507006

Phase 2

Academic-Industrial Partnership for Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

This is a 4-arm, single-center study involving 40 participants. Ten healthy volunteers will be enrolled for system imaging optimization, and thirty (30) patien…

Breast CancerKidney NeoplasmsLiver Neoplasms

Estimated

~$75 – $2,000

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT07225114

Phase 1

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in the Treatment of Subjects With Metastatic Pancreatic Cancer

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in …

Metastatic Pancreatic Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Evopoint Biosciences Inc.NCT07707674

Phase 1

The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study

The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Dis…

Alcohol Use Disorder

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Newleos Therapeutics, Inc.NCT07520292

Observational

Incisional Surgical Site Infection and Fascial Dehiscence After Abdominal Fascial Closure With Triclosan-Coated Barbed Suture vs Polydioxanone Suture After Emergency Exploratory Laparotomy: A Randomized Control Trial

This randomized control trial aims to compare the efficacy of triclosan-coated barbed suture (TCB) versus conventional non-barbed polydioxanone (PDS) suture in…

LaparotomyDehiscence WoundSurgical Site Infections+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Southern CaliforniaNCT06043414

Phase 1

A Phase 1, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetics of Casdatifan (AB521) in Participants With Moderate Hepatic Impairment Compared to Healthy Matched Participants

The purpose of the study is to compare the single dose PK of casdatifan between participants with moderate hepatic impairment (HI) and healthy matched control …

Healthy ParticipantsHepatic Impairment

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Arcus Biosciences, Inc.NCT07751250

Phase 2

Open-Label Phase II Trial of Enfortumab Vedotin in Recurrent or Persistent Endometrial Carcinoma

This study is testing a drug called enfortumab vedotin in up to 12 patients with advanced endometrial (uterine) cancer that has worsened after previous treatme…

Endometrial Cancer

Estimated

~$75 – $3,000

Actual pay is set by the research site.

William BradleyNCT07139977